Canagliflozin as an Initial Therapy in Drug-Naïve Subjects with Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in its Glycemic Efficacy
Crossref DOI link: https://doi.org/10.1007/s40268-017-0179-7
Published Online: 2017-03-11
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kutoh, Eiji
Wada, Asuka
Murayama, Teruma
Takizawa, Yui
License valid from 2017-03-11